Adverse cutaneous reactions associated with the immune checkpoint inhibitor (ICI) pembrolizumab are well documented, yet life-threatening reactions such as Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) are infrequent.1,2 We present a case of pembrolizumab-induced TEN in a patient with metastatic esophageal adenocarcinoma who was successfully treated with cyclosporine and systemic corticosteroids.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9053295 | PMC |
Publication Analysis
Top Keywords
epidermal necrolysis
8
patient metastatic
8
metastatic esophageal
8
esophageal adenocarcinoma
8
pembrolizumab-induced toxic
4
toxic epidermal
4
necrolysis patient
4
adenocarcinoma adverse
4
adverse cutaneous
4
cutaneous reactions
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!